Is EVCM a Good Stock to Buy? The Bull and Bear Case (2026)

Last updated November 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for EverCommerce Inc. (EVCM) rests on Payments attach on an installed base that is already there: EverCommerce processes roughly ~$13.0B of annualized volume for customers whose total payment flow it estimates at more than $100B. The bear case rests on growth is the central problem: ~2.7% reported and ~2.0% pro forma revenue growth with net revenue retention at ~94% describes a business where churn and downgrades are nearly cancelling out new sales and price increases, and management has already guided 2026 to the low end. Analysts covering it publish targets from $7.00 to $11.00 against a $6.37 share price on November 16, 2026, so even the professionals disagree by 48% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

EVCM key stats

At $6.37 on November 16, 2026, EverCommerce Inc. (EVCM) has a market cap of $1.1B and a P/E of 39.8 on trailing earnings (9.3 on forward earnings).

Market cap
$1.1B
P/E (trailing)
39.8
P/E (forward)
9.3
EPS (trailing 12 months)
$0.16
Price to book
1.6
Beta
0.60

Market cap, P/E and yield are measured at the $6.37 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with EverCommerce Inc. (EVCM)?

The last two weeks for EverCommerce Inc., as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • EVCM closed at $6.37 on November 16, 2026, down 21.6% over the past five trading days (from $8.12).
  • On November 5, 2026, EverCommerce Inc. filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
  • On November 5, 2026, EverCommerce Inc. filed an 8-K with the SEC reporting quarterly results (Item 2.02). Read the 8-K on sec.gov
  • On November 9, 2026, Barclays lowered its target to $8.50 from $10.00 (Underweight).
  • On November 6, 2026, Canaccord Genuity lowered its target to $9.00 from $13.00 (Buy).
  • On November 6, 2026, RBC Capital lowered its target to $7.00 from $10.00 (Sector Perform).

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

EverCommerce sells vertically-tailored SaaS to service-based small and medium businesses, organised into three brands: EverPro for home services (contractors, HVAC, roofing, home maintenance), EverHealth for health services (physician practices, therapists) and EverWell for wellness (salons, spas). As of the end of 2025 the platform served more than 745,000 customers. Each vertical follows the same pattern: business management software becomes the system of record for scheduling and job management, then billing and payment solutions ride on top of it, then customer experience tools (reviews, messaging, marketing) layer on. Payments are the monetisation engine, with roughly ~$13.0B of annualized processing volume as of the fourth quarter of 2025 against a customer base the company estimates could eventually run more than $100B through it. Nearly all of the revenue base, about ~97%, is recurring or re-occurring. The company was assembled by acquisition under Providence Strategic Growth and Silver Lake, IPO'd in July 2021 at $17, and has spent the last two years doing the opposite of buying: it sold its Fitness Solutions business in 2025, sold Marketing Technology Solutions in October 2025, and has bought back stock rather than companies. What remains is a cleaner but slower business. Second quarter 2026 revenue of ~$152.0M grew ~2.7% year over year, and only ~2.0% on the company's own pro forma basis, meaning essentially all of the growth is now organic and organic growth is low single digits. Adjusted EBITDA of ~$44.5M was flat against the year-ago quarter, and management guided full-year 2026 results toward the lower end of the ~$612M to ~$632M revenue and ~$183M to ~$191M adjusted EBITDA ranges. Founder Eric Remer stepped down as CEO and Chairman effective August 6, 2026, with Alex Goor taking the seat, and on September 21 Goor reshaped the leadership team: Andrew Hausman (formerly of Dun & Bradstreet) became President of EverPro, Chris Rogers (formerly Instinet's CTO) became Chief Technology Officer, Gim Lau was named Chief Strategy Officer, and EverHealth CRO Brian Caulfield is leading EverHealth on an interim basis after the departures of EverCommerce President Matt Feierstein and EverHealth CEO Evan Berlin. On September 11 the board raised the repurchase authorization by $25M to $325M and extended it through December 31, 2027, funded from cash on hand. The stock jumped about 20% on September 14 after the buyback news; as of October 16, 2026 it closed at ~$9.40, down ~19% year to date and ~15% over one year. The investment question is whether embedded payments and AI-driven workflow tools can lift growth back into the mid single digits, or whether EVCM stays a mid-single-digit-grower carrying ~3.0x gross leverage and a goodwill balance larger than its book equity.

The bull case: what would have to be true for $11.00

The most optimistic published target on EVCM is $11.00, +72.7% from the $6.37 share price on November 16, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Payments attach on an installed base that is already there

EverCommerce processes roughly ~$13.0B of annualized volume for customers whose total payment flow it estimates at more than $100B. Every incremental point of attach converts an existing software relationship into transaction revenue without new customer acquisition cost, which is why subscription and transaction fees (~$147.4M in the June quarter) grew faster than total revenue. The constraint is not addressable volume but the pace at which service SMBs move off legacy processors, and that pace has been slower than the roll-up's original underwriting assumed.

2. Agentic AI as the reason to raise price rather than seats

The company bought ZyraTalk in September 2025 for AI answering and lead capture in home services and has repositioned itself publicly as an AI platform for the service economy. AI voice and scheduling agents matter here because the customer is a contractor who misses calls while on a job, so the product sells against lost revenue rather than against a software budget. Whether that translates into pricing power shows up in net revenue retention, which fell to ~94% in the second quarter of 2026 from ~97% a year earlier.

3. Cash going to the balance sheet and the share count

Trailing operating cash flow of roughly ~$107M against ~$35M of capital expenditure and capitalized software leaves about ~$72M of free cash flow, a ~4.3% yield on the ~$1.66B market cap as of October 16, 2026. Management repurchased ~1.4 million shares for ~$14.8M in the June quarter and ~$28.6M in the first half, taking shares outstanding from ~178.1M to ~176.6M, with ~$19.2M left at June 30 under an authorization then running through December 2026. In September 2026 the board added $25M, taking the program to $325M in total, and extended it through December 31, 2027. Term loan amortisation is modest at ~$5.5M a year, so deleveraging comes mainly from EBITDA rather than repayment.

4. A new CEO, a rebuilt leadership bench and a simplified portfolio

Alex Goor took over on August 6, 2026 after two divestitures removed the marketing technology and fitness businesses that had produced ~$41M of goodwill impairment across 2024 and 2025. The remaining three verticals share a payments layer and a common go-to-market motion, which is a more coherent starting point than the sprawl of 2023. New leadership at a company guiding to the low end of its ranges also carries the usual possibility of a reset quarter, a strategy change or a fresh restructuring charge. Within seven weeks Goor had replaced the leaders of both large verticals: Andrew Hausman now runs EverPro, Brian Caulfield is interim head of EverHealth while a permanent president is recruited, and Chris Rogers (CTO) and Gim Lau (Chief Strategy Officer) joined the executive team, with the company framing the changes around reaccelerating revenue growth. Q3 2026 results on November 5 will be the first full quarter under the new team.

The bear case: what would have to be true for $7.00

The most pessimistic published target is $7.00, +9.9% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks EverCommerce Inc. is worth if the risks below bite instead of the drivers above.

Growth is the central problem: ~2.7% reported and ~2.0% pro forma revenue growth with net revenue retention at ~94% describes a business where churn and downgrades are nearly cancelling out new sales and price increases, and management has already guided 2026 to the low end. The capital structure amplifies that, with ~$523.9M of principal debt against ~$133.5M of cash for roughly ~2.2x net and ~3.0x gross leverage on trailing adjusted EBITDA, on a floating term loan priced at SOFR plus 2.00% (about ~5.65% at June 30, 2026) maturing in July 2030. Goodwill of ~$892.5M and intangibles of ~$142.0M make up roughly ~76% of the ~$1.36B asset base and exceed the ~$715.3M of book equity, so tangible book value is negative and further impairment is a live possibility given the 2024 and 2025 precedents. Ownership is highly concentrated, with PSG at ~48.3% and Silver Lake at ~37.9% as of the April 2026 proxy, leaving a float near 14%, Nasdaq controlled-company status and a steady stream of Form 144 filings, which means a block sale, a take-private or continued sponsor selling are all outcomes a minority holder does not control. A putative class action filed January 31, 2024 in Delaware Chancery (Vladimir Gusinsky Revocable Trust v. Eric Remer, Penny Baldwin, et al., Case No. 2024-0077) challenges the sponsors' veto right over hiring and firing the CEO under DGCL Section 141(a), with oral argument on the motions to dismiss scheduled for October 19, 2026; it is a governance suit seeking declaratory relief, not a securities-fraud claim. Beyond that, the customer base is cyclical home services and small healthcare practices, payments revenue depends on third-party processors including Worldpay and PayPal, and AI-native competitors are attacking the same workflows with lower price points. Execution risk also rose with the September 2026 turnover: both vertical heads and the company's president departed within weeks, and EverHealth is run on an interim basis. EPS has missed consensus in each of the last four reported quarters.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding EVCM already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on EVCM

6 analysts cover EVCM, with an average target of $8.25 (+29.5% against $6.37) and a split of 2 buy, 4 hold, 2 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the EVCM forecast and price target page.

How is EVCM valued?

Market cap, P/E and dividend yield at today's price are in the EVCM key stats above. The business figures below come from EverCommerce Inc.'s reported results as of October 2026 and change when it next reports.

  • Revenue (TTM): ~$598.1M, with Q2 2026 revenue of ~$152.0M up ~2.7% year over year and ~2.0% pro forma
  • Adjusted EBITDA (TTM): ~$175.8M, about a ~29% margin; Q2 2026 was ~$44.5M versus ~$45.0M a year earlier
  • GAAP net income (TTM): ~$34M from continuing operations, or ~$0.05 per share in the June quarter
  • Free cash flow (TTM): ~$72M, from ~$107M of operating cash flow less ~$35M of capital expenditure and capitalized software
  • Net debt and leverage: ~$390M net (~$523.9M principal less ~$133.5M cash), roughly ~2.2x net and ~3.0x gross trailing adjusted EBITDA
  • Q2 2026 EPS vs estimate: ~$0.11 vs ~$0.17 consensus (adjusted basis), a fourth straight miss

As of October 2026: Full-year 2026 guidance calls for ~$612M to ~$632M of revenue and ~$183M to ~$191M of adjusted EBITDA, with management saying in August that results should trend toward the lower end of both. At the October 16, 2026 price that puts the stock near ~11x forward EV/adjusted EBITDA on the low end, which is cheap against high-growth vertical SaaS and unremarkable against a business compounding revenue at ~2%. Goodwill of ~$892.5M against ~$1.36B of total assets is the arithmetic signature of the roll-up: the market is currently valuing the whole enterprise at roughly 2.3x the goodwill carried from past deals. Q3 2026 results on November 5 carry consensus of about ~$152.9M of revenue.

How do you decide if EVCM is a buy?

Whether EVCM is a buy is easier to judge through four narrower questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold EVCM indirectly through an index or sector ETF before adding more.

What would change your mind on EVCM

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Payments attach on an installed base that is already there stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
  • Bear case breaks if: growth is the central problem: ~2.7% reported and ~2.0% pro forma revenue growth with net revenue retention at ~94% describes a business where churn and downgrades are nearly cancelling out new sales and price increases, and management has already guided 2026 to the low end fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the EVCM stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about EVCM against your real portfolio and see your actual exposure before deciding.

Your questions about EverCommerce Inc.

Ask Walnut's AI anything about EVCM and see how it fits what you own.

FAQ

Is EVCM a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Payments attach on an installed base that is already there, with revenue (ttm) at ~$598.1M, with Q2 2026 revenue of ~$152.0M up ~2.7% year over year and ~2.0% pro forma. The bear case rests on growth is the central problem: ~2.7% reported and ~2.0% pro forma revenue growth with net revenue retention at ~94% describes a business where churn and downgrades are nearly cancelling out new sales and price increases, and management has already guided 2026 to the low end. Analysts covering it are spread from $7.00 to $11.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.

Should I sell EVCM?

+

Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Growth is the central problem: ~2.7% reported and ~2.0% pro forma revenue growth with net revenue retention at ~94% describes a business where churn and downgrades are nearly cancelling out new sales and price increases, and management has already guided 2026 to the low end. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $7.00, +9.9% from the $6.37 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.

What is the bull case for EVCM?

+

Payments attach on an installed base that is already there. EverCommerce processes roughly ~$13.0B of annualized volume for customers whose total payment flow it estimates at more than $100B. The most optimistic analyst target on EVCM is $11.00, +72.7% from the $6.37 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for EVCM?

+

Growth is the central problem: ~2.7% reported and ~2.0% pro forma revenue growth with net revenue retention at ~94% describes a business where churn and downgrades are nearly cancelling out new sales and price increases, and management has already guided 2026 to the low end. The capital structure amplifies that, with ~$523.9M of principal debt against ~$133.5M of cash for roughly ~2.2x net and ~3.0x gross leverage on trailing adjusted EBITDA, on a floating term loan priced at SOFR plus 2.00% (about ~5.65% at June 30, 2026) maturing in July 2030. Goodwill of ~$892.5M and intangibles of ~$142.0M make up roughly ~76% of the ~$1.36B asset base and exceed the ~$715.3M of book equity, so tangible book value is negative and further impairment is a live possibility given the 2024 and 2025 precedents. Ownership is highly concentrated, with PSG at ~48.3% and Silver Lake at ~37.9% as of the April 2026 proxy, leaving a float near 14%, Nasdaq controlled-company status and a steady stream of Form 144 filings, which means a block sale, a take-private or continued sponsor selling are all outcomes a minority holder does not control. A putative class action filed January 31, 2024 in Delaware Chancery (Vladimir Gusinsky Revocable Trust v. Eric Remer, Penny Baldwin, et al., Case No. 2024-0077) challenges the sponsors' veto right over hiring and firing the CEO under DGCL Section 141(a), with oral argument on the motions to dismiss scheduled for October 19, 2026; it is a governance suit seeking declaratory relief, not a securities-fraud claim. Beyond that, the customer base is cyclical home services and small healthcare practices, payments revenue depends on third-party processors including Worldpay and PayPal, and AI-native competitors are attacking the same workflows with lower price points. Execution risk also rose with the September 2026 turnover: both vertical heads and the company's president departed within weeks, and EverHealth is run on an interim basis. EPS has missed consensus in each of the last four reported quarters. The most pessimistic published target is $7.00, +9.9% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.

What does EverCommerce Inc. do?

+

Roll-up of vertical SaaS and payments software for service-based small businesses across home services, health services, and fitness and wellness.

What would have to change for EVCM to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Payments attach on an installed base that is already there) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (growth is the central problem: ~2.7% reported and ~2.0% pro forma revenue growth with net revenue retention at ~94% describes a business where churn and downgrades are nearly cancelling out new sales and price increases, and management has already guided 2026 to the low end) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does EverCommerce actually do?

+

It sells vertically-tailored software to service small businesses through three brands: EverPro for home services, EverHealth for medical and therapy practices, and EverWell for salons, spas and wellness. The software handles scheduling, job management, invoicing, customer messaging and reviews, and EverCommerce monetises it further by processing the customer's card and ACH payments. As of the end of 2025 it served more than 745,000 customers, and about ~97% of revenue was recurring or re-occurring.

Is EverCommerce being taken private or delisted?

+

As of mid-August 2026 there is no signed take-private and no delisting process. EverCommerce trades on Nasdaq under EVCM, and its SEC filing history through August 14, 2026 shows no merger 8-K, no Schedule 13E-3 and no merger proxy. The 2025 strategic-alternatives announcement that turns up in search results concerned the Marketing Technology Solutions division only, which was sold in October 2025. Company announcements since then, through October 16, 2026, have covered a larger buyback, leadership changes and the third-quarter earnings date rather than any sale. The reason people speculate is structural: PSG and Silver Lake own roughly 86% of the stock, and the shares trade well below the July 2021 IPO price of $17.

How much of EverCommerce's growth is organic versus acquired?

+

Essentially all of it is organic now, and organic growth is low. Second quarter 2026 revenue grew ~2.7% year over year as reported and ~2.0% on the company's pro forma basis, and the only difference between the two is roughly ~$1M of pre-acquisition revenue from ZyraTalk, bought in September 2025. The acquisition engine that built the company has been idle for over a year while cash has gone to buybacks and debt service instead.

Walnut is informational, not investment advice, and gives no verdict on EVCM. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026. Verify current figures with your broker before acting on them.

The case for and against similar stocks